QQ.L vs. CRL
QQ.L (QinetiQ Group plc) and CRL (Charles River Laboratories International, Inc.) are both stocks. QQ.L operates in Aerospace & Defense (Industrials), while CRL operates in Diagnostics & Research (Healthcare). Over the past 10 years, QQ.L returned 9.42%/yr vs 8.93%/yr for CRL. At a 0.12 correlation, their price movements are largely independent.
Performance
QQ.L vs. CRL - Performance Comparison
Loading charts...
Different Trading Currencies
QQ.L is traded in GBp, while CRL is traded in USD. To make them comparable, the CRL values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, QQ.L achieves a 8.36% return, which is significantly higher than CRL's -5.63% return. Over the past 10 years, QQ.L has outperformed CRL with an annualized return of 9.42%, while CRL has yielded a comparatively lower 8.93% annualized return.
QQ.L
- 1D
- 1.06%
- 1M
- 12.89%
- YTD
- 8.36%
- 6M
- 13.56%
- 1Y
- -12.02%
- 3Y*
- 11.16%
- 5Y*
- 8.50%
- 10Y*
- 9.42%
CRL
- 1D
- 2.78%
- 1M
- 7.24%
- YTD
- -5.63%
- 6M
- -0.53%
- 1Y
- 30.61%
- 3Y*
- -3.85%
- 5Y*
- -10.63%
- 10Y*
- 8.93%
QQ.L vs. CRL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
QQ.L QinetiQ Group plc | 8.36% | 8.34% | 37.22% | -11.50% | 37.15% | -15.08% | -8.68% | 27.80% | 27.13% | -9.87% |
CRL Charles River Laboratories International, Inc. | -5.63% | 0.36% | -20.55% | 3.07% | -35.29% | 52.22% | 58.76% | 29.84% | 9.54% | 31.23% |
Correlation
The correlation between QQ.L and CRL is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.04 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.01 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.06 |
Correlation (All Time) Calculated using the full available price history since Jul 6, 2007 | 0.12 |
The correlation between QQ.L and CRL shifts across timeframes, from 0.01 (5 years) to 0.12 (all time), reflecting how their relationship changes across market environments.
Fundamentals
QQ.L:
£2.48B
CRL:
$9.13B
QQ.L:
-£0.14
CRL:
-$3.75
QQ.L:
0.67
CRL:
2.28
QQ.L:
4.49
CRL:
3.10
QQ.L:
£3.85B
CRL:
$4.03B
QQ.L:
£372.10M
CRL:
$1.00B
QQ.L:
£533.20M
CRL:
$737.05M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
QQ.L vs. CRL — Risk / Return Rank
QQ.L
CRL
QQ.L vs. CRL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for QinetiQ Group plc (QQ.L) and Charles River Laboratories International, Inc. (CRL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| QQ.L | CRL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.08 | ||
| Sortino ratioReturn per unit of downside risk | -1.55 | ||
| Omega ratioGain probability vs. loss probability | 0.96 | 1.16 | -0.20 |
| Calmar ratioReturn relative to maximum drawdown | -0.46 | 0.91 | -1.37 |
| Martin ratioReturn relative to average drawdown | -0.89 | 1.86 | -2.75 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| QQ.L | CRL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.38 | 0.69 | -1.08 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.27 | -0.25 | +0.53 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.33 | 0.24 | +0.09 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.27 | 0.27 | 0.00 |
Drawdowns
QQ.L vs. CRL - Drawdown Comparison
The maximum QQ.L drawdown since its inception was -55.68%, smaller than the maximum CRL drawdown of -77.26%. Use the drawdown chart below to compare losses from any high point for QQ.L and CRL.
Loading charts...
Drawdown Indicators
| QQ.L | CRL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -55.68% | -77.26% | +21.58% |
Max Drawdown (1Y)Largest decline over 1 year | -25.90% | -33.89% | +7.99% |
Max Drawdown (3Y)Largest decline over 3 years | -31.77% | -64.76% | +32.99% |
Max Drawdown (5Y)Largest decline over 5 years | -31.77% | -77.26% | +45.49% |
Max Drawdown (10Y)Largest decline over 10 years | -38.09% | -77.26% | +39.17% |
Current DrawdownCurrent decline from peak | -15.33% | -58.31% | +42.98% |
Average DrawdownAverage peak-to-trough decline | -16.92% | -26.51% | +9.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.72% | 16.47% | -3.75% |
Volatility
QQ.L vs. CRL - Volatility Comparison
The current volatility for QinetiQ Group plc (QQ.L) is 11.81%, while Charles River Laboratories International, Inc. (CRL) has a volatility of 16.40%. This indicates that QQ.L experiences smaller price fluctuations and is considered to be less risky than CRL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| QQ.L | CRL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.81% | 16.40% | -4.59% |
Volatility (6M)Calculated over the trailing 6-month period | 22.30% | 34.55% | -12.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.48% | 44.39% | -12.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.20% | 42.04% | -10.84% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 28.89% | 37.60% | -8.71% |
Dividends
QQ.L vs. CRL - Dividend Comparison
QQ.L's dividend yield for the trailing twelve months is around 1.90%, while CRL has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRL Charles River Laboratories International, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
QQ.L QinetiQ Group plc | 1.90% | 2.00% | 1.99% | 2.49% | 2.04% | 2.59% | 2.06% | 1.84% | 2.20% | 2.60% | 2.17% | 1.99% |
Financials
QQ.L vs. CRL - Financials Comparison
This section allows you to compare key financial metrics between QinetiQ Group plc and Charles River Laboratories International, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
QQ.L vs. CRL - Profitability Comparison
QQ.L - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, QinetiQ Group plc reported a gross profit of 110.20M and revenue of 1.02B. Therefore, the gross margin over that period was 10.8%.
CRL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Charles River Laboratories International, Inc. reported a gross profit of 0.00 and revenue of 995.83M. Therefore, the gross margin over that period was 0.0%.
QQ.L - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, QinetiQ Group plc reported an operating income of 110.20M and revenue of 1.02B, resulting in an operating margin of 10.8%.
CRL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Charles River Laboratories International, Inc. reported an operating income of 119.90M and revenue of 995.83M, resulting in an operating margin of 12.0%.
QQ.L - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, QinetiQ Group plc reported a net income of 69.20M and revenue of 1.02B, resulting in a net margin of 6.8%.
CRL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Charles River Laboratories International, Inc. reported a net income of -14.84M and revenue of 995.83M, resulting in a net margin of -1.5%.
Frequently Asked Questions
QQ.L and CRL have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for QQ.L and CRL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer